MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Peripheral Synucleinopathy in Essential Tremor Plus Patients with Parkinsonian Features and Normal Dopamine Transporter Imaging

    VG. Evidente, T. Levine, D. Evidente, R. Freeman, C. Gibbons (Scottsdale, USA)

    Objective: To describe results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) with parkinsonism. Background: Patients with longstanding ET may…
  • 2023 International Congress

    Impaired Mitophagy and Mitochondrial-energetics in Parkinson’s disease: A Novel Therapeutic Strategy of Re-tasking Felodipine

    A. Roy, S. Choudhury, R. Banerjee, A. Costa, P. Sheshadri, M. Duchen, S. Dey, H. Kumar (Kolkata, India)

    Objective: This study aimed to validate impairment of mitochondrial energetics and mitophagy in PD and the action of felodipine in restoring altered Mitochondria-lysosome (Mito-Lyso) homeostasis.…
  • 2023 International Congress

    Membrane-associated properties and ER stress alterations in LRRK2 I1371V patient iPSC derived neurons increase susceptibility to oxidative stress.

    S. Jagtap, I. Datta (Bengaluru, India)

    Objective: To evaluate the pathophysiology of the midbrain dopaminergic neurons (mDAN) derived from LRRK2 I1371V PD patient-iPSCs leading to susceptibility to oxidative stress. Background: Studies…
  • 2023 International Congress

    Development and quantified evaluation of a continuous smartphone app-based monitoring approach to individualize Parkinson’s disease management.

    F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)

    Objective: The aim of this study is the development and qualified evaluation of a smartphone app-based application to enable a longitudinal assessment of Parkinson’s disease…
  • 2023 International Congress

    Insular dopamine deficits in prodromal α-synucleinopathies

    A. Galli, A. Pilotto, C. Zatti, F. Placidi, F. Izzi, E. Premi, A. Rizzardi, M. Catania, A. Lupini, L. Purin, M. Pasolini, N. Mercuri, A. Chiaravalloti, M. Fernandes, C. Calvello, B. Paghera, D. Berg, A. Padovani, C. Liguori (Brescia, Italy)

    Objective: aim of the study was to evaluate the dopamine binding characterizing subjects both at prodromal and symptomatic stages in α-synucleinopathies, by means of ROI-based…
  • 2023 International Congress

    Short and long-term effects of deep brain stimulation on cognition in Parkinson’s disease

    S. Fjeldhøj, B. Thomsen, P. Pedersen, M. Karlsborg, O. Bergdal, A. Clausen, S. Jensen, B. Jespersen, A. Løkkegaard (Copenhagen, Denmark)

    Objective: To evaluate long-term effects of subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD) on cognition. Background: Cognitive changes are common among patients…
  • 2023 International Congress

    Subthalamic stimulation reshapes the reliable inherent brain state in Parkinson’s disease

    C. Chu, N. He, Z. Zeng, Y. Zhang, X. Wang, Z. Zhang, J. Wang, Y. Wang, Z. Jiang, Y. Lu, B. Sun, F. Yan, D. Li, C. Zhang, C. Liu (Tianjin, China)

    Objective: To elucidate the reliable inherent state of resting-state global brain network and explore the state modulation mechanism of subthalamic stimulation (STN-DBS) on Parkinson’s disease…
  • 2023 International Congress

    SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models

    M. Castelo, G. Gentile, A. Zanon, A. Lavdas, C. Bolduc, M. Picon, S. Laouafa, J. Soliz, M. Lévesque, I. Pichler (Bolzano, Italy)

    Objective: Validate the rescue potential of SLP-2 induction for α-synuclein (aSyn)-induced mitochondrial pathology and neurodegeneration in two complementary models: human induced pluripotent stem cell (hiPSC)-derived…
  • 2023 International Congress

    Long-term effectiveness of adjuvant treatment with catechol-o-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists in Parkinson’s disease uncontrolled by levodopa: final results of the PD MED LATER randomized clinical trial

    C. Clarke, C. Rick, S. Patel, R. Wooley, N. Rowland, J. Futterer, R. Ottridge, C. Jenkinson, R. Gray (Birmingham, United Kingdom)

    Objective: PD MED LATER is a large, pragmatic trial aiming to determine which class of drug when added to levodopa provides the most effective control…
  • 2023 International Congress

    Effects of a nurse-led Advance Care Planning and Care Coordination intervention in Parkinson’s Disease – patient and family caregiver perspectives from a multicentre European study

    C. Muente, BW. Dijkstra, CM. Groot, MJ. Meinders (Nijmegen, Netherlands)

    Objective: To investigate an Advance Care Planning (ACP) and care coordination intervention from the perspective of people with Parkinson's disease (PwPD) and their family caregivers…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley